This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mazumdar A and Derdeyn CP (2006) Fibrinolytic treatment for acute ischaemic stroke. Expert Opin Pharmacother 7: 287–296
del Zoppo GJ et al. (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86
Tomsick T et al. (1996) Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 17: 79–85
Muir KW et al. Imaging of acute stroke. Lancet Neurol 5: 755–768
Hacke W et al. (2005) The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36: 66–73
Acknowledgements
The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Derdeyn, C. Acute ischemic stroke—are hemodynamic variables predictive of outcome after systemic thrombolysis?. Nat Rev Neurol 3, 72–73 (2007). https://doi.org/10.1038/ncpneuro0398
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0398